×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Lung Cancer

Seth Augenstein
Medicaid may not offer as much benefit to those with small-cell lung cancer, a rapidly-spreading disease that requires as fast a response as possible, according to a recent analysis. 
Kristie L. Kahl
In this episode of the "CURE Talks Cancer" podcast, the keynote speaker for the CURE Patient-Focused Sessions at the New York Lung Cancers Symposium shares how a pain under her arm led to her diagnosis in less than 48 hours.
 
Kristie L. Kahl
First-line Tagrisso significantly extended overall survival compared with first generation EGFR-TKIs in patients with Ex19del/L858R EGFR mutated advanced non–small cell lung cancer, according to results from the phase 3 FLAURA study.
Kristie L. Kahl
First-line treatment with Opdivo plus low-dose Yervoy improved survival among patients with advanced NSCLC compared to chemotherapy, according to results from the CheckMate-227 trial.
 
Kristie L. Kahl
A recent survey found that lung cancer stigma can be a barrier to treatment; however, on the plus side, the percentage of people who associate the disease with smoking has dropped in recent years.
Katie Kosko
After a 10-year battle with cancer, the beloved actress, wife, mother and advocate passed away at 80.
Linnea Olson
Traveling helped me remove myself from the storyline of cancer and reconnect with the world around me.
Katie Kosko and Brielle Benyon
Here’s a sneak peek at what’s inside our Summer 2019 issue.
Sponsored Content
Hossein Borghaei, Fox Chase Cancer Center - a physician in the field of cancer care - discusses his experiences treating patients with non-small cell lung cancer and why recent data is now available and could have a positive impact on the treatment landscape. 
Kristie L. Kahl
The American Lung Association’s chief medical officer discusses e-cigarette use and answers common questions surrounding this increasing epidemic.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×